The Hepatic Sinusoid in Aging and Cirrhosis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinical Pharmacokinetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00003088-200544020-00004PMID 15656697
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly

  2012cited by this paper
• Zonal heterogeneity of rat hepatocytes in the in vivo uptake of 17 nm colloidal gold granules

  2004cited by this paper
• Age‐related pseudocapillarization of the human liver

  2003cited by this paper
• Carbon monoxide disposition and permeability-surface area product in the foetal circulation of the perfused term human placenta.

  2003cited by this paper
• Hepatic sinusoidal pseudocapillarization with aging in the non-human primate.

  2003cited by this paper
• Age-Environment and Gene-Environment Interactions in the Pathogenesis of Parkinson's Disease

  2002cited by this paper
• Cationic drug pharmacokinetics in diseased livers determined by fibrosis index, hepatic protein content, microsomal activity, and nature of drug.

  2002cited by this paper
• Vascular permeability in blood capillary

  2002cited by this paper
• Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review

  2002cited by this paper
• Hepatic pseudocapillarisation and atherosclerosis in ageing.

  2002cited by this paper
• Dynamic computed tomography with low- and high-molecular-mass contrast agents to assess microvascular permeability modifications in a model of liver fibrosis.

  2002cited by this paper
• Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry.

  2002cited by this paper
• Transendothelial Transport: The Vesicle Controversy

  2002cited by this paper
• Quantitative evaluation of altered hepatic spaces and membrane transport in fibrotic rat liver

  2002cited by this paper
• Carbon monoxide wash-in method to determine gas transfer in vascular beds: application to rat hindlimb.

  2001cited by this paper
• Pseudocapillarization and associated energy limitation in the aged rat liver

  2001cited by this paper
• Receptor measurements via Tc-GSA kinetic modeling are proportional to functional hepatocellular mass.

  2001cited by this paper
• Liver Function and Phase I Drug Metabolism in the Elderly

  2001cited by this paper
• Postprandial lipoproteins and atherosclerosis.

  2001cited by this paper
• Interpretation of Simultaneous Measurements of Hepatic Extraction Fractions of Indocyanine Green and Sorbitol

  2000cited by this paper
• Acute oxygen supplementation restores markers of hepatocyte energy status and hypoxia in cirrhotic rats.

  2000cited by this paper
• Macromolecule transfer through mesothelium and connective tissue.

  2000cited by this paper
• Hydrodynamic effects on the solute transport across endothelial pores and hepatocyte membranes.

  2000cited by this paper
• Hepatic Artery Flow and Propranolol Metabolism in Perfused Cirrhotic Rat Liver 1

  1999cited by this paper
• The Role of the Sinusoidal Endothelium in Liver Function.

  1999cited by this paper
• On the mechanism of hepatic transendothelial passage of large liposomes

  1999cited by this paper
• Effect of cirrhosis on sulphation by the isolated perfused rat liver.

  1999cited by this paper
• Comparative effects of oxygen supplementation on theophylline and acetaminophen clearance in human cirrhosis.

  1999cited by this paper
• Structure-hepatic disposition relationships for phenolic compounds.

  1999cited by this paper
• 31P and 1H NMR spectroscopic studies of liver extracts of carbon tetrachloride‐treated rats

  1999cited by this paper
• Carbon monoxide disposition in the perfused rat liver.

  1999cited by this paper
• Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.

  1999cited by this paper
• Effects of Liver Disease on Pharmacokinetics

  1999cited by this paper
• Pathways of interstitial fluid and lymph flow in the liver acinus of the sheep and mouse

  1998cited by this paper
• Drug Acetylation in Liver Disease

  1998cited by this paper
• The Aging Liver

  1998cited by this paper
• Assessment of the hepatic circulation in humans: new concepts based on evidence derived from a D-sorbitol clearance method.

  1998cited by this paper
• Age and cytochrome P450‐linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions

  1997cited by this paper
• The hepatic microcirculation in the isolated perfused human liver

  1996cited by this paper
• Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver.

  1996cited by this paper
• Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 2. Hemodynamic and drug disposition studies

  1996cited by this paper
• Role of sinusoidal endothelial cells in liver disease

  1995cited by this paper
• Clinical Pharmacokinetic and Pharmacodynamic Considerations in Patients with Liver Disease

  1995cited by this paper
• Determination of a New 5-Lipoxygenase Inhibitor, Zileuton, and its Inactive N-Dehydroxylated Metabolite in Plasma by High Performance Liquid Chromatography

  1995cited by this paper
• Lipoproteins and the liver sieve: The role of the fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis

  1995cited by this paper
• Oxygen supplementation restores theophylline clearance to normal in cirrhotic rats.

  1995cited by this paper
• Aging, acute oxidative injury and hepatocellular glucose transport in the rat

  1995cited by this paper
• Hepatobiliary function in senescent male sprague‐dawley rats

  1994cited by this paper
• Transport, binding, and metabolism of sulfate conjugates in the liver.

  1994cited by this paper
• The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver.

  1994cited by this paper
• Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolism in vitro and its extraction by the perfused liver in the rat

  1993cited by this paper
• Clearance by the liver in cirrhosis. II. Characterization of propranolol uptake with the multiple‐indicator dilution technique

  1993cited by this paper
• Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis

  1993cited by this paper
• Flow‐limited tracer oxygen distribution in the isolated perfused rat liver: Effects of temperature and hematocrit

  1992cited by this paper
• Uptake of a protein‐bound polar compound, acetaminophen sulfate, by perfused rat liver

  1992cited by this paper
• Aging and the response of the isolated perfused rat liver to vasoactive drugs.

  1992cited by this paper
• Clinical Pharmacokinetics in Patients with Liver Disease

  1991cited by this paper
• Therapeutic implications of impaired hepatic oxygen diffusion in chronic liver disease

  1991cited by this paper
• Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly

  1991cited by this paper
• Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly.

  1988cited by this paper
• Age-Related Changes in Liver Size and Hepatic Blood Flow

  1988cited by this paper
• Nicotine decreases the porosity of the rat liver sieve: a possible mechanism for hypercholesterolaemia.

  1988cited by this paper
• Defenestration of hepatic sinusoids as a cause of hyperlipoproteinaemia in alcoholics.

  1988cited by this paper
• Alcoholic liver injury: Defenestration in noncirrhotic livers—a scanning electron microscopic study

  1987cited by this paper
• A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations

  1986cited by this paper
• HEPATIC MICROCIRCULATION OF LIVER CIRRHOSIS STUDIED BY CORROSION CAST/SCANNING ELECTRON MICROSCOPE EXAMINATION

  1986cited by this paper
• Aging and the liver.

  1986cited by this paper
• Correlation between in‐vitro microsomal enzyme activity and whole organ hepatic elimination kinetics: analysis with a dispersion model

  1986cited by this paper
• The liver sieve: Considerations concerning the structure and function of endothelial fenestrae, the sinusoidal wall and the space of disse

  1985cited by this paper
• Limitations of Tracer Oxygen Uptake in the Canine Coronary Circulation

  1985cited by this paper
• Hepatic circulation in cirrhosis.

  1985cited by this paper
• Hepatic microcirculation in the perfused cirrhotic rat liver.

  1985cited by this paper
• The modeling of tracer exchange and sequestration in the liver.

  1984cited by this paper
• Binding of apolipoprotein E-rich remnant lipoproteins to human liver membranes.

  1984cited by this paper
• The modeling of tracer exchange and sequestration in the liver.

  1984cited by this paper
• Assessment of liver microcirculation in human cirrhosis.

  1982cited by this paper
• Hypoxia and drug metabolism.

  1981cited by this paper
• Liver blood flow. II. Effects of drugs and hormones on liver blood flow.

  1981cited by this paper
• High perfusion pressure damages the sieving ability of sinusoidal endothelium in rat livers.

  1980cited by this paper
• Altered hepatobiliary transport of taurocholic acid in aged rats.

  1980cited by this paper
• Intact hepatocyte theory of impaired drug metabolism in experimental cirrhosis in the rat.

  1979cited by this paper
• Filtration of chylomicrons by the liver may influence cholesterol metabolism and atherosclerosis.

  1978cited by this paper
• Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance

  1977cited by this paper
• Propranolol Disposition in Chronic Liver Disease: A Physiological Approach

  1976cited by this paper
• Uptake of materials by the intact liver. The exchange of glucose across the cell membranes.

  1974cited by this paper
• On the uptake of materials by the intact liver. The transport and net removal of galactose.

  1973cited by this paper
• The transport of cholesterol in thoracic duct lymph of animals fed cholesterol with varying triglyceride loads.

  1969cited by this paper
• The effect of dietary fat load on the size and composition of chylomicrons in thoracic duct lymph.

  1968cited by this paper
• A linear method for determining liver sinusoidal and extravascular volumes.

  1963cited by this paper
• Capillarization of hepatic sinusoids in man.

  1963cited by this paper

• Sublethal stress from polypharmacy modulates scavenging function and fenestrations in mouse liver sinusoidal endothelial cells

  2026cites this paper
• The Immunohistochemical Study of Doxorubicin on Liver and Kidney Tissues in albino Rats

  2025cites this paper
• Metabolic Characteristics of Schisantherin B in Mice with Metabolic-Associated Fatty Liver Disease

  2025cites this paper
• Investigation of the protective role of fisetin against doxorubicin-induced liver injury in rats

  2025cites this paper
• Synthalin, Buformin, Phenformin, and Metformin: A Century of Intestinal “Glucose Excretion” as Oral Antidiabetic Strategy in Overweight/Obese Patients

  2025cites this paper
• Mimicking the Liver Sinusoidal Endothelial Cell Niche In Vitro to Enhance Fenestration in a Genetic Model of Systemic Inflammation

  2025cites this paper
• The Geometric Framework for Nutrition and Its Application to Rodent Models.

  2024cites this paper
• A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement

  2024cites this paper
• Liver Fibrosis Stages Affect Organic Cation Transporter 1/2 Activities in Hepatitis C Virus-Infected Patients

  2024cites this paper
• Liver endothelial cells in NAFLD and transition to NASH and HCC

  2023cites this paper
• Population pharmacokinetics of antibacterial agents in the older population: a literature review

  2023cites this paper
• THYMOQUINONE NANOTHERAPY ABROGATES HEPATOTOXICITY-INDUCED BY DOXORUBICIN IN MALE ALBINO RATS

  2023cites this paper
• Safety and Tolerability of Antimicrobial Agents in the Older Patient

  2023cites this paper
• Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti‐Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis

  2023cites this paper
• Recent advances in liver‐on‐chips: Design, fabrication, and applications

  2023cites this paper
• Effect of caffeine and other xanthines on liver sinusoidal endothelial cell ultrastructure

  2023cites this paper
• Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis

  2023cites this paper
• Intercellular communication among liver cells in the perisinusoidal space of the injured liver: Pathophysiology and therapeutic directions

  2022cites this paper
• Parametric population pharmacokinetics of linezolid: A systematic review

  2022cites this paper
• Effect of liver disease on pharmacokinetics

  2022cites this paper
• Modeling Nonalcoholic Fatty Liver Disease on a Liver Lobule Chip with Dual Blood Supply.

  2021cites this paper
• The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs

  2021cites this paper
• Laminins in metabolic tissues.

  2021cites this paper
• Theory of fluid saturated porous media with surface effects

  2021cites this paper
• An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist.

  2021cites this paper
• Gene Signatures Detect Damaged Liver Sinusoidal Endothelial Cells in Chronic Liver Diseases

  2021cites this paper
• Therapeutic efficacy of lenvatinib in hepatocellular carcinoma patients with portal hypertension

  2020cites this paper
• The Effect of Liver and Kidney Disease on the Pharmacokinetics of Clozapine and Sildenafil: A Physiologically Based Pharmacokinetic Modeling

  2020cites this paper
• Rethinking toxicity testing: Influence of aging on the outcome of long-term toxicity testing and possible remediation.

  2020cites this paper
• DDDT_A_246229 1469..1479

  2020cites this paper
• Population Pharmacokinetics and Dosage Optimization of Linezolid in Patients with Liver Dysfunction

  2020cites this paper
• Pharmacokinetic Considerations for Organ Dysfunction Clinical Trials in Early Drug Development

  2020cites this paper
• Aging and Chronic Liver Disease

  2020cites this paper
• Fenestrations in the Liver Sinusoidal Endothelial Cell

  2020cites this paper
• Hepatic regeneration in aging: Cell type plasticity and redundancies

  2020cites this paper
• Phase I Oncology Drug Development

  2020cites this paper
• Orally Administered Koumine Persists Longer in the Plasma of Aged Rats Than That of Adult Rats as Assessed by Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry

  2020cites this paper
• Prioritization of Therapeutic Targets and Trial Design in Cirrhotic Portal Hypertension

  2019cites this paper
• Pharmacokinetics and Pharmacodynamics of Antibiotics in Transplant Patients

  2019cites this paper
• Ischemia/reperfusion injury in the aged liver: The importance of the sinusoidal endothelium in developing therapeutic strategies for the elderly.

  2019cites this paper
• On-chip optical nanoscopy: towards high throughput and multi-modality

  2019influential citation
• Special Topics in the Care of Older People with HIV

  2019cites this paper
• Medikamentöse Langzeittherapien zur Prognoseverbesserung bei Leberzirrhose und zur Vermeidung von Komplikationen der portalen Hypertension

  2019cites this paper
• Endoscopic Sedation of the Patient With Cirrhosis

  2018cites this paper
• Physiologically Based Pharmacokinetic and Pharmacodynamic Analysis Enabled by Microfluidically Linked Organs-on-Chips.

  2018cites this paper
• Effects of testosterone administration on liver structure and function in aging rats

  2017cites this paper
• Quantitative and integrative analysis of paracrine hepatocyte activation by nonparenchymal cells upon lipopolysaccharide induction

  2017cites this paper
• The Spatiotemporal Accumulation of Myeloid Lineage Cells Is Mapping Out Fibrosis in the Liver after Acute and Chronic Injury

  2017cites this paper
• Pharmacokinetic and pharmacodynamic alterations in older people with dementia

  2017cites this paper
• Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study

  2017cites this paper
• Immunopathology of the Hepatobiliary System

  2017cites this paper
• Pharmacokinetic drug interactions in liver disease: An update.

  2016cites this paper
• Small Vessels – Big Problems : Novel Insights into Microvascular Mechanisms of Diseases Dietary macronutrients and the aging liver sinusoidal endothelial cell X

  2016cites this paper
• Ultrastructure of the liver microcirculation influences hepatic and systemic insulin activity and provides a mechanism for age‐related insulin resistance

  2016cites this paper
• Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics

  2016cites this paper
• Effect of Doxorubicin on Histomorphology of Liver of Wistar Albino Rats

  2016cites this paper
• Ischemia/Reperfusion Injury in the Aged Liver: The Importance of the Sinusoidal Endothelium in Developing Therapeutic Strategies for the Elderly

  2016cites this paper
• The Role of the Liver Sinusoidal Endothelial Cells in the Pathophysiology of Insulin Resistance

  2016cites this paper
• Pharmacotherapy for Mood and Anxiety Disorders

  2016cites this paper
• Chemokine receptors as therapeutic targets in liver disease

  2015cites this paper
• Chip-based optical microscopy for imaging membrane sieve plates of liver scavenger cells

  2015cites this paper
• Effect of Hepatic Impairment on the Pharmacokinetics of Pradigastat, a Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor

  2015cites this paper
• Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.

  2015cites this paper
• Alterations in drug disposition in older adults

  2015influential citation
• Mice with humanized liver endothelium

  2014influential citation
• Some considerations on the predictions of pharmacokinetic alterations in subjects with liver disease

  2014cites this paper
• Use of Anabolic Steroid Altered the Liver Morphology of Rats

  2014cites this paper
• Relevance of liver failure for anti-infective agents: from pharmacokinetic alterations to dosage adjustments

  2014cites this paper
• Analgesia for the cirrhotic patient: A literature review and recommendations

  2014cites this paper
• Pharmacokinetics in children with liver disease : can ex vivo obtained population-specific CYP450 characteristics bridge the knowledge gap?

  2014cites this paper
• Recombinant AAV-mediated Gene Therapy Approaches to Treat Progressive Familial Intrahepatic Cholestasis Type 3

  2014cites this paper
• Liver cell types derived from pluripotent stem cells

  2014cites this paper
• Ultrastructure of the Liver Sinusoid

  2014cites this paper
• A physiologically-based flow network model for hepatic drug elimination II: variable lattice lobule models

  2013cites this paper
• Approaches for dosage individualisation in critically ill patients

  2013cites this paper
• A Sieve-Raft Hypothesis for the regulation of endothelial fenestrations

  2013cites this paper
• Stem cells and liver engineering.

  2013cites this paper
• Clinically Relevant Drug-Drug and Drug-Food Interactions

  2013cites this paper
• Association of liver stiffness with hepatic expression of pharmacokinetically important genes in alcoholic liver disease.

  2013influential citation
• Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan

  2013cites this paper
• Liver immunology.

  2013cites this paper
• Anticoagulant Therapy with the Oral Direct Factor Xa Inhibitors Rivaroxaban, Apixaban and Edoxaban and the Thrombin Inhibitor Dabigatran Etexilate in Patients with Hepatic Impairment

  2013cites this paper
• Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib

  2013cites this paper
• Understanding and managing medication in elderly people.

  2013cites this paper
• [Clinical pharmacology and aging].

  2013cites this paper
• In‐vitro evaluation of chronic alcohol effects on expression of drug‐metabolizing and drug‐transporting proteins

  2013cites this paper
• Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations

  2013cites this paper
• Immunobiology of Plasmodium in liver and brain

  2013cites this paper
• The liver sieve and atherosclerosis

  2012cites this paper
• The Relationship between Fenestrations, Sieve Plates and Rafts in Liver Sinusoidal Endothelial Cells

  2012cites this paper
• Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicines.

  2012influential citation
• Pharmacologie et personnes âgées

  2012cites this paper
• 12 – Vascular disorders

  2012cites this paper
• Drug-related problems and dosage adjustment in patients with liver disease

  2012cites this paper
• The blood concentration and organ distribution of haloperidol at therapeutic and toxic doses in severe fatty liver disease.

  2012cites this paper
• Liver Sinusoidal Endothelial Cells and Regulation of Blood Lipoproteins

  2012cites this paper
• The Influence of Old Age and Poloxamer-407 on the Hepatic Disposition of Diazepam in the Isolated Perfused Rat Liver

  2012cites this paper
• Early‐onset versus late‐onset nonanastomotic biliary strictures post liver transplantation: risk factors reflect different pathogenesis

  2012cites this paper
• Age-Related Changes in the Hepatic Pharmacology and Toxicology of Paracetamol

  2011cites this paper
• Loss of PDGF-B activity increases hepatic vascular 2 permeability and enhances insulin sensitivity 3 4 Running title : PDGF-B deficiency enhances insulin sensitivity 5 6

  2011influential citation